FDA approves Eli Lilly antibody cocktail for COVID-19 prevention

The FDA revised its emergency use authorization for Eli Lilly's COVID-19 antibody cocktail Sept. 16, allowing the treatment to be used as a post-exposure prophylaxis for COVID-19 in individuals who are at high risk for progression to severe COVID-19.